par C347 (Memantine Hydrochloride Extended-Release 14 mg)
Pill with imprint par C347 is Green & Yellow, Capsule-shape and has been identified as Memantine Hydrochloride Extended-Release 14 mg. It is supplied by Par Pharmaceutical, Inc..
Memantine is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 14 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par C347
Memantine Hydrochloride Extended-Release
- Imprint
- par C347
- Strength
- 14 mg
- Color
- Green & Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 10370-0347
- Inactive Ingredients
-
sucrose,
corn starch,
hydroxypropyl cellulose (type e),
magnesium silicate,
ethylcelluloses,
triethyl citrate,
polyethylene glycol 3350,
titanium dioxide,
gelatin,
shellac,
ferrosoferric oxide,
FD&C Blue No. 2,
FD&C Red No. 40,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Yellow No. 6,
FD&C Green No. 3
Note: Inactive ingredients may vary.
More about memantine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 57 Reviews
- Drug class: miscellaneous central nervous system agents
Consumer resources
- Patient Information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
- Other brands
- Namenda, Namenda XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.